Nucleic acid therapeutics: state of the art and future prospects.
Departments of Internal Medicine, Pathology and Laboratory Medicine, and the Institute for Human Gene Therapy, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
A M
AM
Gewirtz
D L
DL
Sokol
M Z
MZ
Ratajczak
D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D001692:Biological Transport; D002986:Clinical Trials as Topic; D005544:Forecasting; D005786:Gene Expression Regulation / Q000187:drug effects*; D018390:Gene Targeting; D015316:Genetic Therapy; D019337:Hematologic Neoplasms / Q000235:genetics / Q000628:therapy; D006801:Humans; D008958:Models, Molecular; D016376:Oligonucleotides, Antisense / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D009857:Oncogenes; D016337:RNA, Catalytic / Q000378:metabolism; D013873:Thionucleotides / Q000494:pharmacology; D013917:Thrombin / Q000037:antagonists & inhibitors; D019851:Thrombophilia / Q000628:therapy; D014157:Transcription Factors / Q000037:antagonists & inhibitors / Q000235:genetics; D014158:Transcription, Genetic / Q000187:drug effects
D000925:Anticoagulants; D016376:Oligonucleotides, Antisense; D016337:RNA, Catalytic; D013873:Thionucleotides; D014157:Transcription Factors; D013917:Thrombin